RecruitingNCT07390591

Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

Intravesical Gentamicin Coupled With Lactobacillus Rhamnosus for Urinary Health- Early Career


Sponsor

Medstar Health Research Institute

Enrollment

60 participants

Start Date

Jun 19, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is: 1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations. Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.


Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • Criteria for patients:
  • Age 18+
  • Diagnosis of NLUTD
  • Chronic catheter usage (minimum 6 months), either intermittent catheterization or indwelling catheter
  • Community-dwelling
  • Experience using intravesical Lactobacillus, gentamicin, or combination of the two
  • Criteria for caregivers:
  • Age 18+
  • Care for patient with diagnosis of NLUTD
  • Care for patient who has used catheters chronically (minimum 6 months)
  • Experience facilitating patients' use of intravesical Lactobacillus, gentamicin, or combination of the two

Exclusion Criteria1

  • Psychiatric or psychologic conditions impacting ability to consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Medstar National Rehabilitation Hospital

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07390591


Related Trials